[The agreed experts' position of the Eurasian Association of Therapists on tactics of management of patients with comorbid pathology infected with SARS-Cov-2].

COVID-19 QT interval SARS-Cov-2 bronchial asthma chronic kidney disease chronic obstructive pulmonary disease coagulopathy diabetes mellitus

Journal

Terapevticheskii arkhiv
ISSN: 0040-3660
Titre abrégé: Ter Arkh
Pays: Russia (Federation)
ID NLM: 2984818R

Informations de publication

Date de publication:
14 Oct 2020
Historique:
received: 13 10 2020
accepted: 13 10 2020
entrez: 21 12 2020
pubmed: 22 12 2020
medline: 23 12 2020
Statut: epublish

Résumé

The agreement of experts of the Eurasian Association of Therapists (EAT) discusses pathogenesis and treatment of COVID-19. Modern data on the characteristics of cardiovascular, kidney, respiratory damage in SARS-infected CoV-2 are presented. The tactics of managing patients initially having cardiovascular diseases, diabetes mellitus, chronic obstructive pulmonary disease, bronchial asthma, chronic kidney disease are discussed in detail. The article presents data on drug interaction of drugs. В соглашении экспертов Евразийской ассоциации терапевтов (ЕАТ) обсуждаются вопросы патогенеза и лечения COVID-19. Представлены современные данные об особенностях поражения сердечно-сосудистой системы, почек, органов дыхания у инфицированных SARS-Cov-2. Подробно обсуждена тактика ведения пациентов, исходно имеющих сердечно-сосудистые заболевания, сахарный диабет, хроническую обструктивную болезнь легких, бронхиальную астму, хроническую болезнь почек. В статье представлены данные о лекарственном взаимодействии препаратов.

Autres résumés

Type: Publisher (rus)
В соглашении экспертов Евразийской ассоциации терапевтов (ЕАТ) обсуждаются вопросы патогенеза и лечения COVID-19. Представлены современные данные об особенностях поражения сердечно-сосудистой системы, почек, органов дыхания у инфицированных SARS-Cov-2. Подробно обсуждена тактика ведения пациентов, исходно имеющих сердечно-сосудистые заболевания, сахарный диабет, хроническую обструктивную болезнь легких, бронхиальную астму, хроническую болезнь почек. В статье представлены данные о лекарственном взаимодействии препаратов.

Identifiants

pubmed: 33346439
doi: 10.26442/00403660.2020.09.000703
doi:

Types de publication

Journal Article

Langues

rus

Sous-ensembles de citation

IM

Pagination

108-124

Auteurs

G P Arutiunov (GP)

Pirogov Russian National Research Medical University.

E I Tarlovskaia (EI)

Volga Research Medical University.

N A Koziolova (NA)

Wagner Perm State Medical University.

M V Boldina (MV)

Volga Research Medical University.

M M Batiushin (MM)

Rostov State Medical University.

A S Ametov (AS)

Russian Medical Academy of Continuous Professional Education.

A G Arutiunov (AG)

Pirogov Russian National Research Medical University.

A S Belevskii (AS)

Pirogov Russian National Research Medical University.

G R Galstian (GR)

Endocrinology Research Centre.

N I Grigor'eva (NI)

Volga Research Medical University.

G A Dzhunusbekova (GA)

Kazakh Medical University of Continuing Education.

A M Esaian (AM)

Pavlov First Saint Petersburg State Medical University.

S V Mal'chikova (SV)

Kirov State Medical University.

N P Mit'kovskaia (NP)

Belarusian State Medical University.

A M Mkrtumian (AM)

Yevdokimov Moscow State University of Medicine and Dentistry.

I A Orlova (IA)

Lomonosov Moscow State University.

M M Petrova (MM)

Voino-Yasenetski Krasnoyarsk State Medical University.

A P Rebrov (AP)

Razumovsky Saratov State Medical University.

D I Ruzanov (DI)

Gomel State Medical University.

V V Salukhov (VV)

Kirov Military Medical Academy.

A S Sisakian (AS)

Yerevan State Medical University.

V V Skibitskii (VV)

Kuban State Medical University.

A B Sugraliev (AB)

Asfendiyarov Kazakh National Medical University.

I V Fomin (IV)

Volga Research Medical University.

I S Khalimov (IS)

Kirov Military Medical Academy.

A I Chesnikova (AI)

Rostov State Medical University.

I I Shaposhnik (II)

South Ural State Medical University.

M V Shestakova (MV)

Endocrinology Research Centre.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH